A carregar...

PARP inhibition causes premature loss of cohesion in cancer cells

Poly(ADP-ribose) polymerases (PARPs) regulate various aspects of cellular function including mitotic progression. Although PARP inhibitors have been undergoing various clinical trials and the PARP1/2 inhibitor olaparib was approved as monotherapy for BRCA-mutated ovarian cancer, their mode of action...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Kukolj, Eva, Kaufmann, Tanja, Dick, Amalie E., Zeillinger, Robert, Gerlich, Daniel W., Slade, Dea
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5732777/
https://ncbi.nlm.nih.gov/pubmed/29262611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21879
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!